Skip to main content

Hodgkin Lymphoma in Patients with HIV Infection

  • Living reference work entry
  • First Online:
Encyclopedia of AIDS

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Berenguer J, Miralles P, Ribera JM, et al. Characteristics and outcome of AIDS related Hodgkin Lymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47:422–8.

    Article  PubMed  CAS  Google Scholar 

  • Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786–91.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis. 2009;48(5):633–9.

    Article  PubMed  Google Scholar 

  • Carbone A, Gloghini A, Larocca LM, et al. Human immunodeficiency virus associated Hodgkin’s disease derives from post-germinal center B cells. Blood. 1999;93:2319–26.

    PubMed  CAS  Google Scholar 

  • Chimienti E, Spina M, Gastaldi R, et al. Clinical characteristics and outcome of 290 patients (pts) with Hodgkin’s disease and HIV infection (HD-HIV) in pre and HAART (highly active antiretroviral therapy) era. Ann Oncol. 2008;19:iv136, abs 168.

    Google Scholar 

  • Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.

    Article  PubMed  Google Scholar 

  • Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985–1998. Br J Cancer. 2003;89:94–100.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Dolcetti R, Boiocchi M, Gloghini A, Carbone A. Pathogenetic and histogenetic features of HIV-associated Hodgkin’s disease. Eur J Cancer. 2001;37(10):1276–87.

    Article  PubMed  CAS  Google Scholar 

  • Errante D, Tirelli U, Gastaldi R, et al. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin’s disease and human immunodeficiency virus infection. A prospective study of 17 patients. Cancer. 1994;73:437–44.

    Article  PubMed  CAS  Google Scholar 

  • Errante D, Gabarre J, Ridolfo AL, et al. Hodgkin’s disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol. 1999;10:189–95.

    Article  PubMed  CAS  Google Scholar 

  • Gallamini A, Rigacci L, Merli F, et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin’s disease. Haematologica. 2006;91(4):475–81.

    PubMed  Google Scholar 

  • Gloghini A, Carbone A. Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity? Int J Cancer. 2007;120:2753–4.

    Article  PubMed  CAS  Google Scholar 

  • Hartmann P, Rehwald U, Salzberger B, et al. BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection. Ann Oncol. 2003;14:1562–9.

    Article  PubMed  CAS  Google Scholar 

  • Hentrich M, Berger M, Wyen C, et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study. J Clin Oncol. 2012;30:4117–23.

    Article  PubMed  Google Scholar 

  • Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8:22–33.

    Article  PubMed  CAS  Google Scholar 

  • Levine AM, Li P, Cheung T, et al. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine and dacarbazine with granulocyte-colony-stimulating factor CSF in HIV infected patients with newly diagnosed Hodgkin’s disease: a prospective, multi-institutional AIDS Clinical Trials Group study (ACTG 149). J Acquir Immune Defic Syndr. 2000;24:444–50.

    Article  PubMed  CAS  Google Scholar 

  • Montoto S, Shaw K, Okosun J, et al. HIV status does not influence the outcome in patients with classical Hodgkin Lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30:4111–6.

    Article  PubMed  Google Scholar 

  • Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27(6):884–90.

    Article  PubMed  Google Scholar 

  • Re A, Michieli M, Casari S, et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood. 2009;114(7):1306–13.

    Article  PubMed  CAS  Google Scholar 

  • Serraino D, Pezzotti P, Dorrucci M, et al. Cancer incidence in a cohort of human immunodeficiency virus seroconveters. HIV Italian Seroconverters Study Group. Cancer. 1997;79:1004–8.

    Article  PubMed  CAS  Google Scholar 

  • Spina M, Gabarre J, Rossi G, et al. Stanford V and concomitant HAART in 59 patients with Hodgkin’s disease and HIV infection. Blood. 2002;100:1984–8.

    Article  PubMed  CAS  Google Scholar 

  • Spina M, Rossi G, Antinori A, et al. VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV). Ann Oncol. 2008;19:iv152, abs 227.

    Google Scholar 

  • Tirelli U, Errante D, Dolcetti R, et al. Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol. 1995;13:1758–67.

    PubMed  CAS  Google Scholar 

  • Vaccher E, Spina M, Talamini R, et al. Improvement of systemic human immunodeficiency virus-related NHL in the era of HAART. Clin Infect Dis. 2003;37:1556–64.

    Article  PubMed  Google Scholar 

  • Xicoy B, Ribera JM, Miralles P, et al. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage human immunodeficiency virus-related Hodgkin’s lymphoma. Haematologica. 2007;92:191–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Spina .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Spina, M., Ciancia, R., Augello, A., Berretta, M., Tirelli, U. (2013). Hodgkin Lymphoma in Patients with HIV Infection. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_26-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_26-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics